Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of Shiga toxins produced by Escherichia coli

Journal of Medicinal Chemistry

Volumn 55, Issue 6, 2012, Pages 2702-2710

  Li, Xuebing ^a   Wu, Peixing ^b,c,d   Cheng, Shuihong ^a   Lv, Xun ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b Key Laboratory of New Animal Drug Project   (China)

^c AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^d INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; ANTIBIOTIC AGENT; CHITOSAN DERIVATIVE; GLOBOTRIOSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG SYNTHESIS; ESCHERICHIA COLI INFECTION; FEMALE; HEMOLYTIC UREMIC SYNDROME; MOUSE; NONHUMAN; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; VERO CELL;

ANIMALS; ANTI-BACTERIAL AGENTS; CARBOHYDRATE SEQUENCE; CERCOPITHECUS AETHIOPS; CHITOSAN; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC-UREMIC SYNDROME; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; SHIGA TOXINS; TRISACCHARIDES; VERO CELLS;

EID: 84863380563     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201570s     Document Type: Article

References (63)

1. Bertozzi, C. R.; Kiessling, L. L. Chemical glycobiology Science 2001, 291, 2357-2364 (Pubitemid 32231790)
2. Weis, W. I.; Drickamer, K. Structural basis of lectin-carbohydrate recognition Annu. Rev. Biochem. 1996, 65, 441-473 (Pubitemid 26250616)
3. Mammen, M.; Choi, S. K.; Whitesides, G. M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. 1998, 37, 2754-2794 (Pubitemid 29008561)
4. Duncan, R. The dawning era of polymer therapeutics Nat. Rev. Drug Discovery 2003, 2, 347-360 (Pubitemid 37361705)
5. Kumar, M. N.; Muzzarelli, R. A.; Muzzarelli, C.; Sashiwa, H.; Domb, A. J. Chitosan chemistry and pharmaceutical perspectives Chem. Rev. 2004, 104, 6017-6084 (Pubitemid 40025733)
6. Suh, J. K. F.; Matthew, H. W. T. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review Biomaterials 2000, 21, 2589-2598
7. Agnihotri, S. A.; Mallikarjuna, N. N.; Aminabhavi, T. M. Recent advances on chitosan-based micro- and nanoparticles in drug delivery J. Controlled Release 2004, 100, 5-28 (Pubitemid 39445982)
8. Yi, H.; Wu, L. Q.; Bentley, W. E.; Ghodssi, R.; Rubloff, G. W.; Culver, J. N.; Payne, G. F. Biofabrication with chitosan Biomacromolecules 2005, 6, 2881-2894 (Pubitemid 41764041)
9. Li, X.; Wu, P.; Gao, G. F.; Cheng, S. Carbohydrate-functionalized chitosan fiber for influenza virus capture Biomacromolecules 2011, 12, 3962-3969
10. Xu, Y.; Fan, H.; Lu, C.; Gao, G. F.; Li, X. Synthesis of galabiose-chitosan conjugate as potent inhibitor of Streptococcus suis adhesion Biomacromolecules 2010, 11, 1701-1704
11. Han, J.; Li, X. Chemoenzymatic syntheses of sialyl Lewis X-chitosan conjugate as potential anti-inflammatory agent Carbohydr. Polym. 2011, 83, 137-143
12. Paton, J. C.; Paton, A. W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections Clin. Microbiol. Rev. 1998, 11, 450-479 (Pubitemid 28379095)
13. Boyce, T. G.; Swerdlow, D. L.; Griffin, P. M. Escherichia coli O157:H7 and the hemolytic-uremic syndrome N. Engl. J. Med. 1995, 333, 364-368
14. Varma, J. K.; Greene, K. D.; Reller, M. E.; DeLong, S. M.; Trottier, J.; Nowicki, S. F.; DiOrio, M.; Koch, E. M.; Bannerman, T. L.; York, S. T.; Lambert-Fair, M. A.; Wells, J. G.; Mead, P. S. An outbreak of Escherichia coli O157 infection following exposure to a contaminated building JAMA, J. Am Med. Assoc. 2003, 290, 2709-2712 (Pubitemid 37475599)
15. Wong, C. S.; Jelacic, S.; Habeeb, R. L.; Watkins, S. L.; Tarr, P. I. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections N. Engl. J. Med. 2000, 342, 1930-1936 (Pubitemid 30419087)
16. Johannes, L.; Römer, W. Shiga toxins: from cell biology to biomedical applications Nat. Rev. Microbiol. 2010, 8, 105-116
17. Kitov, P. I.; Sadowska, J. M.; Mulvey, G.; Armstrong, G. D.; Ling, H.; Pannu, N. S.; Read, R. J.; Bundle, D. R. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands Nature 2000, 403, 669-672 (Pubitemid 30104009)
18. Mulvey, G. L.; Marcato, P.; Kitov, P. I.; Sadowska, J.; Bundle, D. R.; Armstrong, G. D. Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands J. Infect. Dis. 2003, 187, 640-649 (Pubitemid 36250028)
19. Takeda, T.; Yoshino, K.; Adachi, E.; Sato, Y; Yamagata, K. In vitro assessment of a chemically synthesized Shiga toxin receptor analogue attached to chromosorb P (Synsorb-Pk) as a specific absorbing agent of Shiga toxin 1 and 2 Microbiol. Immunol. 1999, 43, 331-337 (Pubitemid 29194202)
20. Trachtman, H.; Cnaan, A.; Christen, E.; Gibbs, K.; Zhao, S.; Acheson, D. W.; Weiss, R.; Kaskel, F. J.; Spitzer, A.; Hirschman, G. H. Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial JAMA, J. Am. Med. Assoc. 2003, 290, 1337-1344 (Pubitemid 37442630)
21. Nishikawa, K.; Matsuoka, K.; Kita, E.; Okabe, N.; Mizuguchi, M.; Hino, K.; Miyazawa, S.; Yamasaki, C.; Aoki, J.; Takashima, S.; Yamakawa, Y.; Nishijima, M.; Terunuma, D.; Kuzuhara, H.; Natori, Y. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7 Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 7669-7674 (Pubitemid 34568749)
22. Watanabe, M.; Matsuoka, K.; Kita, E.; Igai, K.; Higashi, N.; Miyagawa, A.; Watanabe, T.; Yanoshita, R.; Samejima, Y.; Terunuma, D.; Natori, Y.; Nishikawa, K. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections J. Infect. Dis. 2004, 189, 360-368 (Pubitemid 38210571)
23. Paton, A. W.; Morona, R.; Paton, J. C. A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans Nat. Med. 2000, 6, 265-270 (Pubitemid 30148617)
24. Pinyon, R. A.; Paton, J. C.; Paton, A. W.; Botten, J. A; Morona, R. Refinement of a therapeutic Shiga toxin-binding probiotic for human trials J. Infect. Dis. 2004, 189, 1547-1555 (Pubitemid 38648281)
25. Paton, A. W.; Morona, R.; Paton, J. C. Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose Infect. Immun. 2001, 69, 1967-1970 (Pubitemid 32187666)
26. Paton, J. C.; Rogers, T. J.; Morona, R.; Paton., A. W. Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli Infect. Immun. 2001, 69, 1389-1393 (Pubitemid 32187585)
27. Miyagawa, A.; Watanabe, M.; Igai, K.; Kasuya, M. C.; Natori, Y.; Nishikawa, K.; Hatanaka, K. Development of dialyzer with immobilized glycoconjugate polymers for removal of Shiga-toxin Biomaterials 2006, 27, 3304-3311 (Pubitemid 43344341)
28. Miyagawa, A.; Kasuya, M. C. Z.; Hatanaka, K. Inhibitory effects of glycopolymers having globotriose and/or lactose on cytotoxicity of Shiga toxin 1 Carbohydr. Polym. 2007, 67, 260-264 (Pubitemid 44751154)
29. Kulkarni, A. A.; Fulle, C.; Korman, H.; Weiss, A. A.; Iyer, S. Glycan encapsulated gold nanoparticles selectively inhibit Shiga toxins 1 and 2 Bioconjugate Chem. 2010, 21, 1486-1493
30. Watanabe, M.; Igai, K.; Matsuoka, K.; Miyagawa, A.; Watanabe, T.; Yanoshita, R.; Samejima, Y.; Terunuma, D.; Natori, Y.; Nishikawa, K. Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues Infect. Immun. 2006, 74, 1984-1988 (Pubitemid 43346841)
31. 2-derivatives conjugated with a phosphatidyl residue: a novel class of Shiga toxin-neutralizing agent Biol. Pharm. Bull. 2007, 30, 1697-1701 (Pubitemid 47403248)
32. Armstrong, G. D.; Fodor, E.; Vanmaele, R. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences J. Infect. Dis. 1991, 164, 1160-1167
33. Kitov, P. I.; Lipinski, T.; Paszkiewicz, E.; Solomon, D.; Sadowska, J. M.; Grant, G. A.; Mulvey, G. L.; Kitova, E. N.; Klassen, J. S.; Armstrong, G. D.; Bundle, D. R. An entropically efficient supramolecular inhibition strategy for Shiga toxins Angew. Chem., Int. Ed. 2008, 47, 672-676
34. Lundquist, J. J.; Debenham, S. D.; Toone, E. J. Multivalency effects in protein-carbohydrate interaction: the binding of the Shiga-like toxin 1 binding subunit to multivalent C-linked glycopeptides J. Org. Chem. 2000, 65, 8245-8250
35. 2 and galacto-trehalose models against Shiga toxins Microbiol. Immunol. 2007, 51, 581-592 (Pubitemid 46974975)
36. Dohi, H.; Nishida, Y.; Mizuno, M.; Shinkai, M.; Kobayashi, T.; Takeda, T.; Uzawa, H.; Kobayashi, K. Synthesis of an artificial glycoconjugate polymer carrying Pk-antigenic trisaccharide and its potent neutralization activity against Shiga-like toxin Bioorg. Med. Chem. 1999, 7, 2053-2062 (Pubitemid 29457704)
37. 5 toxins Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 16837-16842
38. 3) J. Am. Chem. Soc. 1988, 110, 7910-7912
39. Park, T. K.; Kim, I. J.; Hu, S.; Bilodeau, M. T.; Randolph, J. T.; Kwon, O.; Danishefsky, S. J. Total synthesis and proof of structure of a human breast tumor (Globo-H) antigen J. Am. Chem. Soc. 1996, 118, 11488-11500 (Pubitemid 26399680)
40. Zhu, T.; Boons, G. J. A Two-directional and highly convergent approach for the synthesis of the tumor-associated antigen globo-H Angew. Chem., Int. Ed. 1999, 38, 3495-3497
41. Wang, Z.; Zhou, L.; El-Boubbou, K.; Ye, X. S.; Huang, X. Multi-component one-pot synthesis of the tumor-associated carbohydrate antigen Globo-H based on preactivation of thioglycosyl donors J. Org. Chem. 2007, 72, 6409-6420 (Pubitemid 47267562)
42. Pfäffli, P. J.; Hixson, S. H.; Anderson, L. Thioglycosides having O -benzyl blocking groups as intermediates for the systematic, sequential synthesis of oligosaccharides. Synthesis of isomaltose Carbohydr. Res. 1972, 23, 195-206
43. Onoda, T.; Shirai, R.; Iwasaki, S. A mild and selective deprotection of p -methoxybenzyl (PMB) ether by magnesium bromide diethyl etherate-methyl sulfide Tetrahedron Lett. 1997, 38, 1443-1446 (Pubitemid 27085536)
44. Yu, W.; Su, M.; Gao, X.; Yang, Z.; Jin, Z. A facile chemoselective deprotection of the p -methoxybenzyl group Tetrahedron Lett. 2000, 41, 4015-4017 (Pubitemid 30367323)
45. Matsuoka, K.; Terabatake, M.; Esumi, Y.; Terunuma, D.; Kuzuhara, H. Synthetic assembly of trisaccharide moieties of globotriaosyl ceramide using carbosilane dendrimers as cores. a new type of functional glyco-material Tetrahedron Lett. 1999, 40, 7839-7842 (Pubitemid 29487934)
46. 3) Carbohydr. Res. 1990, 202, 177-191
47. Rinaudo, M. Chitin and chitosan: properties and applications Prog. Polym. Sci. 2006, 31, 603-632 (Pubitemid 44287019)
48. Plant, A. L.; Brigham-Burke, M.; Petrella, E. C.; O'Shannessy, D. J. Phospholipid/alkanethiol bilayers for cell-surface receptor studies by surface plasmon resonance Anal. Biochem. 1995, 226, 342-348
49. Gershon, P. D.; Khilko, S. Stable chelating linkage for reversible immobilization of oligohistidine tagged proteins in the BIAcore surface plasmon resonance detector J. Immunol. Methods 1995, 183, 65-76
50. Lee, Y. C.; Lee, R. T. Carbohydrate-protein interactions: basis of glycobiology Acc. Chem. Res. 1995, 28, 321-327
51. Lundquist, J. J.; Toone, E. The cluster glycoside effect J. Chem. Rev. 2002, 102, 555-578 (Pubitemid 35377623)
52. Geng, J.; Mantovani, G.; Tao, L.; Nicolas, J.; Chen, G. J.; Wallis, R.; Mitchell, D. A.; Johnson, B. R.; Evans, S. D.; Haddleton, D. M. Site-directed conjugation of "clicked" glycopolymers to form glycoprotein mimics: binding to mammalian lectin and induction of immunological function J. Am. Chem. Soc. 2007, 129, 15156-15163 (Pubitemid 350247799)
53. Becer, C. R.; Gibson, M. I.; Geng, J.; llyas, R.; Wallis, R.; Mitchell, D. A.; Haddleton, D. M. High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein J. Am. Chem. Soc. 2010, 132, 15130-15132
54. St Hilaire, P. M.; Boyd, M. K.; Toone, E. J. Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor Biochemistry 1994, 33, 14452-14463
55. Kale, R. R.; McGannon, C. M.; Fuller-Schaefer, C.; Hatch, D. M.; Flagler, M. J.; Gamage, S. D.; Weiss, A. A.; Iyer, S. S. Differentiation between structurally homologous Shiga 1 and Shiga 2 toxins by using synthetic glycoconjugates Angew. Chem., Int. Ed. 2008, 47, 1265-1268
56. 3) mimics: surface-specific affinity with Shiga toxins Anal. Biochem. 2002, 310, 27-35 (Pubitemid 35387327)
57. Boerlin, P.; McEwen, S. A.; Boerlin-Petzold, F.; Wilson, J. B.; Johnson, R. P.; Gyles, C. L. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans J. Clin. Microbiol. 1999, 37, 497-503 (Pubitemid 29091254)
58. Rutjes, N. W.; Binnington, B. A.; Smith, C. R.; Maloney, M. D.; Lingwood, C. A. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model Kidney Int. 2002, 62, 832-845 (Pubitemid 35316712)
59. Kurioka, T.; Yunou, Y.; Kita, E. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice Infect. Immun. 1998, 66, 1726-1734 (Pubitemid 128471540)
60. Schiller, R. N.; Barrager, E.; Schauss, A. G.; Nichols, E. J. A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals J. Am. Nutraceutical Assoc. 2001, 4, 42-49
61. No, H. K.; Park, N. Y.; Lee, S. H.; Meyers, S. P. Antibacterial activity of chitosans and chitosan oligomers with different molecular weights Int. J. Food Microbiol. 2002, 74, 65-72 (Pubitemid 34203704)
62. Noda, M.; Yutsudo, T.; Nakabayashi, N.; Hirayama, T.; Takeda, Y. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin Microb. Pathog. 1987, 2, 339-349 (Pubitemid 17096443)
63. Yutsudo, T.; Nakabayashi, N.; Hirayama, T.; Takeda, Y. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin Microb. Pathog. 1987, 3, 21-30